Economic Burden of Hiv/Aids in Myanmar : provider perspective

Abstract

This study emphasizes on how to estimate the provider direct cost for the treatment and prevention of HIV/AIDS patients in Myanmar for the next 5 years. Since there is no such study conducted in Myanmar, it is a good starting point for further and more in-depth study. This thesis is a methodologic study using a costing model which calculates the cost of treatment and prevention of HIV/AIDS patients. HIV/AIDS cases are projected for the next 5 years and the cost to be incurred by the Government is projected by Epimodel. In order to calculate the cost of treatment and investigation, the data were collected from 40 AIDS patients admitted to the Infectious Diseases Hospital, Yangon, Myanmar from April 1 1994 to March 31 1995. The calculation of the cost of prevention was based on the information obtained from discussion with health personnel from the Central Health Education Bureau, Department of Health, Myanmar. HIV point prevalence is estimated based on sentinel surveillance reports. Variables required for insertion in the Epimodel are also estimated. Baseline, medium and high intervention scenarios of HIV/AIDS are constructed by using some assumptions. In this study, the economic burden of HIV/AIDS according to different scenarios is calculated and costs for each cost item and each activity in each scenario in each year are calculated and compared. Given the assumptions, the total provider costs for HIV/AIDS with and without screening are 644.2 million kyats and 560 million kyats respectively for the next 5 years in baseline interventions.